Glutamate receptor modulator
Phase 1
Therapeutic Area: Central Nervous System (CNS)
This compound is under investigation, further information will be available soon.
Phase 1
Therapeutic Area: Central Nervous System (CNS)
This compound is under investigation, further information will be available soon.